Prognostic Value of sST2 in Heart Failure

被引：19
|
作者：
Sciatti, Edoardo [1 ]
Merlo, Anna [2 ]
Scangiuzzi, Claudio [2 ]
Limonta, Raul [2 ]
Gori, Mauro [1 ]
D'Elia, Emilia [1 ]
Aimo, Alberto [3 ,4 ]
Vergaro, Giuseppe [3 ,4 ]
Emdin, Michele [3 ,4 ]
Senni, Michele [1 ,2 ]
机构：
[1] ASST Papa Giovanni XXIII, Cardiol Unit, I-24127 Bergamo, Italy
[2] Univ Milano Bicocca, Sch Med & Surg, I-20126 Milan, Italy
[3] Scuola Super Sant Anna, Hlth Sci Interdisciplinary Ctr, I-56127 Pisa, Italy
[4] Fdn Toscana G Monasterio, I-56124 Pisa, Italy
来源：
JOURNAL OF CLINICAL MEDICINE | 2023年 / 12卷 / 12期
关键词：
ST2; heart failure; biomarker; natriuretic peptide; prognosis; SENSITIVITY TROPONIN-T; SOLUBLE ST2; NATRIURETIC PEPTIDE; MYOCARDIAL FIBROSIS; RISK STRATIFICATION; BIOMARKERS; MORTALITY; RECEPTOR; PREDICTION; MANAGEMENT;
D O I：
10.3390/jcm12123970
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In recent years, there has been growing interest in the risk stratification for heart failure, and the use of multiple biomarkers to identify different pathophysiological processes associated with this condition. One such biomarker is soluble suppression of tumorigenicity-2 (sST2), which has shown some potential for integration into clinical practice. sST2 is produced by both cardiac fibroblasts and cardiomyocytes in response to myocardial stress. Other sources of sST2 are endothelial cells of the aorta and coronary arteries and immune cells such as T cells. Indeed, ST2 is also associated with inflammatory and immune processes. We aimed at reviewing the prognostic value of sST2 in both chronic and acute heart failure. In this setting, we also provide a flowchart about its potential use in clinical practice.
引用
收藏
页数：10
相关论文
共 50 条
  • [41] The mortality implications of increasing and decreasing sST2 levels during acute decompensated heart failure
    Li, B.
    Dowley, M.
    Langley, S.
    Cliffe, P.
    Whiting, S.
    Zydzik, L.
    Dimarco, A.
    Barbagallo, R.
    Dungu, J. N.
    Savage, H. O.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [42] Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction
    Cui, Yameng
    Qi, Xin
    Huang, Anan
    Li, Jiao
    Hou, Wenguang
    Liu, Keqiang
    MEDICAL SCIENCE MONITOR, 2018, 24 : 5139 - 5146
  • [43] Prognostic Value of Circulating sST2 for the Prediction of Mortality in Patients With Cardiac Light-Chain Amyloidosis
    Zhang, Yang
    Xiao, Ying
    Liu, Yongtai
    Fang, Quan
    Tian, Zhuang
    Li, Jian
    Zhou, Daobin
    Xie, Zhongpeng
    Dong, Ruijia
    Zhang, Shuyang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 7
  • [44] SST2 and galectin provide additional prognostic information when compared to NT-proBNP, proBNP and BNP in ambulatory patient with heart failure
    Curinier, C.
    Roubille, F. Francois
    Davy, J. M.
    Cristol, J. P.
    Kuster, N.
    Leclercq, F.
    Pasquie, J. L.
    Solecki, K.
    Ricci, J. E.
    Dupuy, A. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 419 - 419
  • [45] Soluble Suppression of Tumorigenicity-2 (sst2) Predicts Mortality and Right Heart Failure in Lvad Patients
    Numan, L.
    Aarts, E.
    Ramjankhan, F.
    Van der Meer, M. G.
    Oerlemans, M.
    De Jonge, N.
    Oppelaar, A.
    Kemperman, H.
    Asselbergs, F.
    Van Laake, L. W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S364 - S365
  • [46] Dynamic Right Ventricular Changes in Heart Failure: Insights From Serum sST2 and Strain Imaging
    Kamal, Ahmed Mohamed
    Abdelhamid, Magdy
    Darweesh, Reham
    Hassan, Mohamed
    IRANIAN HEART JOURNAL, 2023, 24 (04): : 42 - 53
  • [47] PREDICTING HEART FAILURE IN PATIENTS WITH DIABETES MELLITUS: GALECTIN-3, SST2, AND CAROTID THICKNESS
    Herashchenko, A. S.
    Fedorov, S. V.
    Bielinskyi, M. V.
    Seredyuk, N. M.
    Ivano-Frankivsk, I. V. Kozlova
    WORLD OF MEDICINE AND BIOLOGY, 2023, 84 (02): : 45 - 49
  • [48] Association of point-of-care testing for sST2 with clinical outcomes in patients hospitalized with heart failure
    Chen, Yuyi
    Guan, Jingyuan
    Qi, Chen
    Wu, Yihang
    Wang, Jing
    Zhao, Xuemei
    Li, Xinqing
    He, Chunhui
    Zhang, Jian
    Zhang, Yuhui
    ESC HEART FAILURE, 2024, 11 (05): : 2481 - +
  • [49] Expression and Clinical Significance of Serum sST2, BDNF, CTnI, and BUN/Cr in Patients With Heart Failure
    Xie, Cui
    Zhan, Yu
    Wu, You
    Zhang, Zhixin
    Xiang, Yang
    Wang, Lin
    Chen, Dan
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2023, 29 (01) : 176 - 181
  • [50] Diagnostic values of NT-proBNP and sST2 in patients with acute coronary syndrome and heart failure
    Barnett, O. Olga
    Halkevych, M.
    Kyyak, Y.
    Labinska, O.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 106 - 106
12345